药代-话题@MedSci

#药代#

158篇内容 | 3045人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1666661, encodeId=f36f1666661c6, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=安徽省：药代实名备案，签廉洁合同！, objectType=article, longId=108191, objectId=494d10819134, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=494d10819134, replyNumber=0, likeNumber=65, createdTime=2017-12-29, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=494d10819134, moduleTitle=安徽省：药代实名备案，签廉洁合同！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=494d10819134)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666658, encodeId=8576166665864, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=刚刚，医院试用人脸识别系统监控医药代表了！, objectType=article, longId=102947, objectId=633810294ea7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=633810294ea7, replyNumber=0, likeNumber=0, createdTime=2018-03-25, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=633810294ea7, moduleTitle=刚刚，医院试用人脸识别系统监控医药代表了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=633810294ea7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666635, encodeId=9f5316666356f, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=大封杀！禁止医药代表擅自进医院！, objectType=article, longId=86013, objectId=464b860138c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=464b860138c, replyNumber=0, likeNumber=67, createdTime=2017-05-10, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=464b860138c, moduleTitle=大封杀！禁止医药代表擅自进医院！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=464b860138c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666638, encodeId=ff7d16666380c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=叕上央视，三明模式推全国：药代被抓、第三方查医生、药企写保证......., objectType=article, longId=86352, objectId=6c1786352c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c1786352c6, replyNumber=0, likeNumber=59, createdTime=2017-08-02, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c1786352c6, moduleTitle=叕上央视，三明模式推全国：药代被抓、第三方查医生、药企写保证......., moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c1786352c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666667, encodeId=0474166666ea3, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=史上严格：上海连发3文件严控医药代表和医生, objectType=article, longId=112809, objectId=8e0e11280934, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e0e11280934, replyNumber=0, likeNumber=62, createdTime=2018-05-26, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e0e11280934, moduleTitle=史上严格：上海连发3文件严控医药代表和医生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e0e11280934)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666669, encodeId=59ad166666913, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=国发新规发布如何看药代“不得卖药”？, objectType=article, longId=115992, objectId=e43f1159922a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e43f1159922a, replyNumber=0, likeNumber=74, createdTime=2018-09-23, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e43f1159922a, moduleTitle=国发新规发布如何看药代“不得卖药”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e43f1159922a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666652, encodeId=d0ad1666652bc, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=医疗反腐大动作：东莞纪委出动严查医生药代！, objectType=article, longId=99432, objectId=00c699432b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00c699432b8, replyNumber=0, likeNumber=75, createdTime=2018-02-06, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00c699432b8, moduleTitle=医疗反腐大动作：东莞纪委出动严查医生药代！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00c699432b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666644, encodeId=feaa1666644c0, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=医改大潮中的医药代表转型后仍有可为, objectType=article, longId=89011, objectId=3f16890117e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f16890117e, replyNumber=0, likeNumber=68, createdTime=2017-02-16, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f16890117e, moduleTitle=医改大潮中的医药代表转型后仍有可为, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f16890117e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666656, encodeId=5fcd166665661, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=CLIN PHARMACOKINET：1型糖尿病患者速效型胰岛素的药代动力学和药效学特征, objectType=article, longId=100541, objectId=5f5410054125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f5410054125, replyNumber=0, likeNumber=62, createdTime=2017-12-22, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f5410054125, moduleTitle=CLIN PHARMACOKINET：1型糖尿病患者速效型胰岛素的药代动力学和药效学特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f5410054125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666639, encodeId=ec411666639d6, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=有关部门开始下达抓药代“指标”了！, objectType=article, longId=86393, objectId=121f8639370, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=121f8639370, replyNumber=0, likeNumber=62, createdTime=2017-06-08, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=121f8639370, moduleTitle=有关部门开始下达抓药代“指标”了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=121f8639370)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666655, encodeId=c9211666655e0, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=CLIN PHARMACOKINET：抗逆转录病毒药物和CYP2C9 / CYP2C19多态性对Etravirine药代动力学的影响？, objectType=article, longId=100535, objectId=2246100535ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2246100535ac, replyNumber=0, likeNumber=31, createdTime=2017-07-20, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2246100535ac, moduleTitle=CLIN PHARMACOKINET：抗逆转录病毒药物和CYP2C9 / CYP2C19多态性对Etravirine药代动力学的影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2246100535ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666641, encodeId=c03116666413c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=国务院：300万医药代表全部登记备案！不得承担销售任务, objectType=article, longId=88597, objectId=cbe58859e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbe58859e9f, replyNumber=0, likeNumber=78, createdTime=2017-02-27, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbe58859e9f, moduleTitle=国务院：300万医药代表全部登记备案！不得承担销售任务, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbe58859e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666654, encodeId=dca41666654be, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=CLIN PHARMACOKINET：Necitumumab在癌症患者中的群体药代动力学如何？, objectType=article, longId=100531, objectId=077010053178, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=077010053178, replyNumber=0, likeNumber=96, createdTime=2018-04-11, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=077010053178, moduleTitle=CLIN PHARMACOKINET：Necitumumab在癌症患者中的群体药代动力学如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=077010053178)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666653, encodeId=89451666653ce, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=贵州药代备案管理时间表确定明年6月底前实施, objectType=article, longId=100505, objectId=2aab10050510, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2aab10050510, replyNumber=0, likeNumber=69, createdTime=2018-04-03, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2aab10050510, moduleTitle=贵州药代备案管理时间表确定明年6月底前实施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2aab10050510)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666642, encodeId=c07a16666426d, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=医药代表是否是药价虚高的“刽子手”?, objectType=article, longId=88613, objectId=c0d088613cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0d088613cb, replyNumber=0, likeNumber=80, createdTime=2017-06-26, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0d088613cb, moduleTitle=医药代表是否是药价虚高的“刽子手”?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0d088613cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666648, encodeId=a18116666486f, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=医药代表竟成“毒贩” 专卖这种“咳嗽水” 看到请当心！, objectType=article, longId=93325, objectId=47e493325d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47e493325d0, replyNumber=0, likeNumber=64, createdTime=2017-12-03, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47e493325d0, moduleTitle=医药代表竟成“毒贩” 专卖这种“咳嗽水” 看到请当心！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47e493325d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666646, encodeId=68b41666646a4, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=三甲医院亮出“新武器”严防药代, objectType=article, longId=91482, objectId=7b8d9148213, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b8d9148213, replyNumber=0, likeNumber=66, createdTime=2017-07-19, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b8d9148213, moduleTitle=三甲医院亮出“新武器”严防药代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b8d9148213)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666637, encodeId=1dbe166663ea6, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=震惊！央视知名记者深挖医药代表变迁史, objectType=article, longId=86339, objectId=b5c4863394e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5c4863394e, replyNumber=0, likeNumber=94, createdTime=2017-10-04, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5c4863394e, moduleTitle=震惊！央视知名记者深挖医药代表变迁史, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5c4863394e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666640, encodeId=9caa16666406c, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=国务院重磅：医药代表备案，只能从事学术推广、技术咨询等活动, objectType=article, longId=88547, objectId=a9f08854e4b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9f08854e4b, replyNumber=0, likeNumber=58, createdTime=2017-03-02, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9f08854e4b, moduleTitle=国务院重磅：医药代表备案，只能从事学术推广、技术咨询等活动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9f08854e4b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1666645, encodeId=e88a166664592, content=<a href='/topic/show?id=df6a8e287d7' target=_blank style='color:#2F92EE;'>#药代#</a>, objectTitle=传医药代表被抓，国家卫计委内部发文反腐, objectType=article, longId=89255, objectId=43f88925579, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43f88925579, replyNumber=0, likeNumber=62, createdTime=2017-05-09, rootId=0, userName=fengyqf, userId=bccf26064950, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43f88925579, moduleTitle=传医药代表被抓，国家卫计委内部发文反腐, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43f88925579)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药代

2020-05-29

fengyqf (审核中...)

前往app查看评论内容

#药代#

安徽省：药代实名备案，签廉洁合同！

2017-12-29

fengyqf (审核中...)

前往app查看评论内容

#药代#

刚刚，医院试用人脸识别系统监控医药代表了！

2018-03-25

fengyqf (审核中...)

前往app查看评论内容

#药代#

大封杀！禁止医药代表擅自进医院！

2017-05-10

fengyqf (审核中...)

前往app查看评论内容

#药代#

叕上央视，三明模式推全国：药代被抓、第三方查医生、药企写保证.......

2017-08-02

fengyqf (审核中...)

前往app查看评论内容

#药代#

史上严格：上海连发3文件严控医药代表和医生

2018-05-26

fengyqf (审核中...)

前往app查看评论内容

#药代#

国发新规发布如何看药代“不得卖药”？

2018-09-23

fengyqf (审核中...)

前往app查看评论内容

#药代#

医疗反腐大动作：东莞纪委出动严查医生药代！

2018-02-06

fengyqf (审核中...)

前往app查看评论内容

#药代#

医改大潮中的医药代表转型后仍有可为

2017-02-16

fengyqf (审核中...)

前往app查看评论内容

#药代#

CLIN PHARMACOKINET：1型糖尿病患者速效型胰岛素的药代动力学和药效学特征

2017-12-22

fengyqf (审核中...)

前往app查看评论内容

#药代#

有关部门开始下达抓药代“指标”了！

2017-06-08

fengyqf (审核中...)

前往app查看评论内容

#药代#

CLIN PHARMACOKINET：抗逆转录病毒药物和CYP2C9 / CYP2C19多态性对Etravirine药代动力学的影响？

2017-07-20

fengyqf (审核中...)

前往app查看评论内容

#药代#

国务院：300万医药代表全部登记备案！不得承担销售任务

2017-02-27

fengyqf (审核中...)

前往app查看评论内容

#药代#

CLIN PHARMACOKINET：Necitumumab在癌症患者中的群体药代动力学如何？

2018-04-11

fengyqf (审核中...)

前往app查看评论内容

#药代#

贵州药代备案管理时间表确定明年6月底前实施

2018-04-03

fengyqf (审核中...)

前往app查看评论内容

#药代#

医药代表是否是药价虚高的“刽子手”?

2017-06-26

fengyqf (审核中...)

前往app查看评论内容

#药代#

医药代表竟成“毒贩” 专卖这种“咳嗽水” 看到请当心！

2017-12-03

fengyqf (审核中...)

前往app查看评论内容

#药代#

三甲医院亮出“新武器”严防药代

2017-07-19

fengyqf (审核中...)

前往app查看评论内容

#药代#

震惊！央视知名记者深挖医药代表变迁史

2017-10-04

fengyqf (审核中...)

前往app查看评论内容

#药代#

国务院重磅：医药代表备案，只能从事学术推广、技术咨询等活动

2017-03-02

fengyqf (审核中...)

前往app查看评论内容

#药代#

传医药代表被抓，国家卫计委内部发文反腐

2017-05-09

科室
- - 订阅+
  - 更多科室
工具
服务